home / stock / otlc / otlc quote
Last: | $0.032 |
---|---|
Change Percent: | 0.0% |
Open: | $0.031 |
Close: | $0.032 |
High: | $0.032 |
Low: | $0.0305 |
Volume: | 4,000 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.032 | $0.031 | $0.032 | $0.032 | $0.0305 | 4,000 | 07-04-2024 |
$0.032 | $0.031 | $0.032 | $0.032 | $0.0305 | 4,000 | 07-03-2024 |
$0.0305 | $0.0315 | $0.0305 | $0.0315 | $0.0305 | 1,000 | 07-02-2024 |
$0.03053 | $0.0316 | $0.03053 | $0.032 | $0.03053 | 96,599 | 07-01-2024 |
$0.0325 | $0.0325 | $0.0325 | $0.0325 | $0.0325 | 5,628 | 06-28-2024 |
$0.033 | $0.031 | $0.033 | $0.033 | $0.031 | 11,008 | 06-27-2024 |
$0.032 | $0.033 | $0.032 | $0.033 | $0.031 | 30,828 | 06-26-2024 |
$0.031 | $0.0335 | $0.031 | $0.0335 | $0.031 | 23,713 | 06-25-2024 |
$0.0335 | $0.034 | $0.0335 | $0.034 | $0.0335 | 1,500 | 06-24-2024 |
$0.035 | $0.034 | $0.035 | $0.035 | $0.0335 | 204,321 | 06-21-2024 |
$0.033335 | $0.0335 | $0.033335 | $0.03425 | $0.0321 | 144,265 | 06-20-2024 |
$0.0343 | $0.0345 | $0.03425 | $0.0345 | $0.034 | 80,400 | 06-19-2024 |
$0.03425 | $0.0345 | $0.03425 | $0.0345 | $0.034 | 80,400 | 06-18-2024 |
$0.0343 | $0.039 | $0.0343 | $0.039 | $0.0321 | 278,483 | 06-17-2024 |
$0.0393 | $0.039 | $0.0393 | $0.0399 | $0.039 | 4,300 | 06-14-2024 |
$0.0393 | $0.0393 | $0.0393 | $0.0393 | $0.0393 | 593 | 06-13-2024 |
$0.0397 | $0.04 | $0.0397 | $0.04 | $0.039 | 16,770 | 06-12-2024 |
$0.0399 | $0.039 | $0.0399 | $0.0399 | $0.039 | 13,903 | 06-11-2024 |
$0.038 | $0.04 | $0.038 | $0.04 | $0.036 | 6,814 | 06-10-2024 |
$0.0365 | $0.037 | $0.0365 | $0.0375 | $0.0365 | 64,500 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Oncotelic Therapeutics Inc Company Name:
OTLC Stock Symbol:
OTCMKTS Market:
Oncotelic Therapeutics Inc Website:
AGOURA HILLS, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will speak at the 20th Annual Congress of International Drug Discovery Science & Technology (IDDST) (Europe), June 17-19, 2024 at Budapest, Hungary. ...
AGOURA HILLS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will be participating at the BIO International 2024 meeting on June3-6, San Diego. The BIO International Convention is the largest and most comprehensive event ...
AGOURA HILLS, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its Chief Clinical Officer- Dr. Anthony Maida will be participating at the ASCO 2024 meeting. Abstract: e16318. Meta-analysis comparing the incidence of serious adverse events, ov...